833-PET-HERO(833-738-4376)

Clinical Information

With thousands of pets treated by PetCure-delivered radiation therapy since 2015, our core mission is to help pets with cancer. We work hard to improve clinical outcomes through research, clinical trials and the never-ending optimization of evidence-based protocols. We strive to provide the best possible outcome for every pet that we treat, and every pet that we treat helps improve future outcomes by contributing to cancer research.

Click on any of the links below to download .pdf versions of these resources.

 

Published, Peer-Reviewed Journal Articles

2019 (March) – Efficacy and toxicity of mustargen, vincristine, procarbazine and prednisone (MOPP) for the treatment of relapsed or resistant lymphoma in cats

2019 (March) – Outcomes and adverse effects associated with stereotactic body radiation therapy in dogs with nasal tumors: 28 cases (2011-2016)

2018 (August) – Retrospective survey of owners’ experiences with palliative radiation therapy for pets

Coming Soon: Soft Tissue Sarcoma (Article approved; Publication in JAVMA scheduled for January 2020)

 

Information for Veterinarians

Preliminary Outcomes Data Analysis (presented at VCS 2019)

Active Clinical Trials (Immune Cell Activation; Lung Tumors)

Teleconsultation and Remote Support

SRS/SRT – When should I use it? A reference guide for veterinarians

SRS/SRT – What can it treat, where can I find it, and does it work?

Case Studies (video & print)

 

Information for Pet Owners

Pet Cancer eGuide

About PetCure and stereotactic radiation (SRS/SRT)

Talking to Your Veterinarian About Cancer

Tumor Info Sheet – Brain

Tumor Info Sheet – Mast Cell

BACK TO TOP